MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Cognitive and Psychiatric Correlates of Fear of Falling in Progressive Supranuclear Palsy and Multiple System Atrophy

    V. Martinez-Villota, C. Terroba-Chambi Chambi, S. Castillo-Torres, M. Rossi, M. Merello (Buenos Aires, Argentina)

    Objective: To evaluate the clinical correlates of fear of falling (FoF) in patients with Progressive Supranuclear Palsy (PSP) and Multiple System Atrophy (MSA) Background: FoF…
  • 2022 International Congress

    Dopamine agonist utilization prior to the initiation of device aided therapy: data from 150 patients with advanced Parkinson’s disease treated with Levodopa Carbidopa Intestinal Gel

    J. Szasz, V. Constantin, K. Orban-Kis, L. Bancu, S. Bataga, R. Neagoe, J. Szederjesi, B. Grigorescu, M. Ciorba, I. Mihaly, K. Kelemen, S. Szatmari (Targu Mures, Romania)

    Objective: Objective: To evaluate the usage of dopamine agonists (DA) as part of the last conventional dopaminergic treatment in a large cohort of consecutive patients…
  • 2022 International Congress

    Electrophysiology and clinical description of Tremor in Spinocerebellar Ataxia 12 (SCA12)

    A. Srivastava, M. Narang, R. Rajan, M. Faruq (New Delhi, India)

    Objective: To describe the clinical and electrophysiological characteristics of tremor in SCA12. Background: There is scarcity of literature on tremor of SCA12 patients which is…
  • 2022 International Congress

    Levosulpiride and Movement Disorders–A Growing Concern

    D. Radhakrishnan, S. Gomathy, R. Rajan, A. Srivastava, A. Das, A. Agarwal, A. Pandit, V. Goyal (New Delhi, India)

    Objective: To describe a series of patients with levosulpiride (LVS) induced movement disorders (LIM) evaluated at a single movement disorder center, the All India Institute…
  • 2022 International Congress

    Concomitant Medication Use and Levodopa Equivalent Daily Dose Requirements After Foslevodopa/foscarbidopa Initiation

    D. Santos Garcia, L. Bergmann, B. Bergmans, F. Bergquist, S. Criswell, V. Fung, J. Jia, P. Kukreja, N. Pavasia, W. Robieson, Z. Zhang, D. Standaert (A Coruña, Spain)

    Objective: To evaluate patterns of concomitant medication use and levodopa equivalent daily dose (LEDD) during a 52 week study with foslevodopa/foscarbidopa (LDP/CDP). Background: LDP/CDP is…
  • 2022 International Congress

    Throat Clearing tics In Wilson’s Disease- An Unusual Manifestation

    V H. Ganaraja, A. Konnur, S. Kodapala (BENGALURU, India)

    Objective: To report unusual presentation of throat clearing tics in a 15 year old Indian girl with Wilson’s disease (WD). Background: WD is one of…
  • 2022 International Congress

    A case of levodopa responsive parkinsonism due to methanol toxicity, an impact of COVID-19 crisis

    M. Shah, L. Patil, M. Bhatt (Mumbai, India)

    Objective: To report the clinical course of secondary parkinsonism due to methanol toxicity with good levodopa responsiveness in the background of COVID-19 crisis. Background: The…
  • 2022 International Congress

    Edentulous stereotypy: Common lacunae in the identification of an old malady

    D. Desai, S. Desai (Anand, India)

    Objective: To characterize the common errors or pitfalls in the recognition of edentulous stereotypy Background: Edentulous stereotypy is a well-characterized abnormal movement of the jaw…
  • 2022 International Congress

    BIOMARKERS OF PARKINSONISM AND POSSIBILITIES OF PREDICTION OF THE COURSE OF PARKINSON’S DISEASE

    D. Akramova, K. Daminova (Tashkent, Uzbekistan)

    Objective: Parkinsonism is one of the most significant problems in clinical neurology, both due to its high prevalence in the world's populations and due to…
  • 2022 International Congress

    Mortality in Parkinson’s patients following Covid19 infection in the second wave of the pandemic

    G. Desai, T. Nanayakkara, G. Pun, A. Chatterjee, N. Butt (Reading, United Kingdom)

    Objective: To analyze causes of mortality and death certification in Parkinson’s disease patients who had SARS- CoV2 in Reading, West Berkshire, United Kingdom (UK) Background:…
  • « Previous Page
  • 1
  • …
  • 34
  • 35
  • 36
  • 37
  • 38
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley